Harvard Scientists Uncover How Gut Bacteria Fuel Inflammation and Depression
Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.
Too Old to Operate8d
Risks of AEs With Mirtazapine in Major Depressive Disorder
The following is a summary of “Risks of adverse events with mirtazapine for adults with major depressive disorder: a ...
Automated voice analysis can diagnose multiple mental health disorders in one minute
It's no secret that there is a mental health crisis in the United States. As of 2021, 8.3% of adults had major depressive ...
Science Daily2d
Listening for multiple mental health disorders
Researchers develop machine learning tools that screen for co-morbid anxiety disorders and major depressive disorder using acoustic voice signals. The team spoke to participants with and without ...
Alto Neuroscience, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
EurekAlert!10d
A new global study aims to map the brain signatures of bipolar disorder to transform understanding of the disease
A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural ...
Alaska Dispatch News13d
I think my friend might have bipolar disorder. How can I help him?
People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...
Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment
Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.
psychiatryadvisor.com9d
Preventive Interventions Effective for Subthreshold Depressive Symptoms
(HealthDay News) — Preventive psychological interventions may be effective for adults with subthreshold depressive symptoms, according to a review published online in the December issue of The Lancet ...
Morningstar10d
Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment
Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder. The San Diego ...